How to buy CONMED Corporation stock | $102.27

CONMED Corporation is a medical devices business based in the US. CONMED Corporation shares (CNMD) are listed on the NYSE and all prices are listed in US Dollars. CONMED Corporation employs 3,300 staff and has a trailing 12-month revenue of around USD$874.5 million.

How to buy shares in CONMED Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for CONMED Corporation. Find the stock by name or ticker symbol: CNMD. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CONMED Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$102.27, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of CONMED Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of CONMED Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

CONMED Corporation share price

Use our graph to track the performance of CNMD stocks over time.

CONMED Corporation shares at a glance

• Key figures

Information last updated 2020-12-01.

Latest market close	USD$102.27
52-week range	USD$37.4668 - USD$114.3325
50-day moving average	USD$89.5511
200-day moving average	USD$81.618
Wall St. target price	USD$95.5
PE ratio	11420
Dividend yield	USD$0.8 (0.76%)
Earnings per share (TTM)	USD$0.009

Buy CONMED Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy CONMED Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of CONMED Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CONMED Corporation price performance over time

Historical closes compared with the close of $102.27 from 2020-12-04

1 week (2020-11-25)	-2.08%
1 month (2020-11-06)	27.36%
3 months (2020-09-04)	19.61%
6 months (2020-06-05)	25.09%

1 year (2019-12-05)	-10.22%
2 years (2018-12-04)	52.66%
3 years (2017-12-05)	96.45%
5 years (2015-12-04)	139.90%

Is CONMED Corporation under- or over-valued?

Valuing CONMED Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CONMED Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CONMED Corporation's P/E ratio

CONMED Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11420x. In other words, CONMED Corporation shares trade at around 11420x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CONMED Corporation's PEG ratio

CONMED Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CONMED Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CONMED Corporation's EBITDA

CONMED Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$143.5 million.

The EBITDA is a measure of a CONMED Corporation's overall financial performance and is widely used to measure a its profitability.

CONMED Corporation financials

Revenue TTM	USD$874.5 million
Operating margin TTM	8.51%
Gross profit TTM	USD$528.9 million
Return on assets TTM	2.66%
Return on equity TTM	0.05%
Profit margin	0.04%
Book value	$23.889
Market capitalisation	USD$2.9 billion

TTM: trailing 12 months

Shorting CONMED Corporation shares

There are currently 846,967 CONMED Corporation shares held short by investors – that's known as CONMED Corporation's "short interest". This figure is 17.2% down from 1.0 million last month.

There are a few different ways that this level of interest in shorting CONMED Corporation shares can be evaluated.

CONMED Corporation's "short interest ratio" (SIR)

CONMED Corporation's "short interest ratio" (SIR) is the quantity of CONMED Corporation shares currently shorted divided by the average quantity of CONMED Corporation shares traded daily (recently around 174993.18181818). CONMED Corporation's SIR currently stands at 4.84. In other words for every 100,000 CONMED Corporation shares traded daily on the market, roughly 4840 shares are currently held short.

However CONMED Corporation's short interest can also be evaluated against the total number of CONMED Corporation shares, or, against the total number of tradable CONMED Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CONMED Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 CONMED Corporation shares in existence, roughly 50 shares are currently held short) or 0.0767% of the tradable shares (for every 100,000 tradable CONMED Corporation shares, roughly 77 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CONMED Corporation.

Find out more about how you can short CONMED Corporation stock.

CONMED Corporation share dividends

Dividend payout ratio: 36.04% of net profits

Recently CONMED Corporation has paid out, on average, around 36.04% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.76% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CONMED Corporation shareholders could enjoy a 0.76% return on their shares, in the form of dividend payments. In CONMED Corporation's case, that would currently equate to about $0.8 per share.

While CONMED Corporation's payout ratio might seem fairly standard, it's worth remembering that CONMED Corporation may be investing much of the rest of its net profits in future growth.

CONMED Corporation's most recent dividend payout was on 5 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 December 2020 (the "ex-dividend date").

Have CONMED Corporation's shares ever split?

CONMED Corporation's shares were split on a 3:2 basis on 10 September 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CONMED Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CONMED Corporation shares which in turn could have impacted CONMED Corporation's share price.

CONMED Corporation share price volatility

Over the last 12 months, CONMED Corporation's shares have ranged in value from as little as $37.4668 up to $114.3325. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CONMED Corporation's is 1.4019. This would suggest that CONMED Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

CONMED Corporation overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

Frequently asked questions

• What percentage of CONMED Corporation is owned by insiders or institutions?

  Currently 4.187% of CONMED Corporation shares are held by insiders and 107.026% by institutions.

• How many people work for CONMED Corporation?

  Latest data suggests 3,300 work at CONMED Corporation.

• When does the fiscal year end for CONMED Corporation?

  CONMED Corporation's fiscal year ends in December.

• Where is CONMED Corporation based?

  CONMED Corporation's address is: 525 French Road, Utica, NY, United States, 13502

• What is CONMED Corporation's ISIN number?

  CONMED Corporation's international securities identification number is: US2074101013

• What is CONMED Corporation's CUSIP number?

  CONMED Corporation's Committee on Uniform Securities Identification Procedures number is: 207410101